Clinical Trial

Trident II Tritanium Acetabular Shell Outcomes Study

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to review the performance and success rate of an FDA approved cementless hip replacement part called the Trident II Tritanium Acetabular Shell. The study will specifically look at the need to revise the hip replacement after 5 years. This will be compared to how much this happens in patients who have hip replacement with similar cementless acetabular shells.
Protocol Amendment History 21 amendments
This ClinicalTrials.gov record has been amended 21 times since 2016-12-16; most recent amendment 2026-06-25.
Status change: Recruiting → Active, Not Recruiting 2023-12-07
Status change: Not Yet Recruiting → Recruiting 2017-01-24
Trial Details
NCT Number NCT02999009
Lead Sponsor Stryker Orthopaedics
Conditions Arthroplasty, Replacement, Hip
Enrollment 383 participants
Start Date 2017-01-20
Primary Completion 2026-06-10 (estimated)
Study Completion 2031-03 (estimated)
Updated on ClinicalTrials.gov 2026-06-29